Thus, the AFAP1-AS1/miR-7-5p/EGFR axis was closely associated with the progression and gemcitabine tolerance of cervical cancer cells, providing potential targets for the treatment of cervical cancer. The gene discussed is EGFR; the disease is cervical cancer.